STOCK TITAN

APTOSE BIOSCIENCES INC (APTOF) Free Cash Flow by Year

APTOF

APTOSE BIOSCIENCES INC recorded an outflow of $22.0M in free cash flow in fiscal year 2025. This represents an increase of 38.9% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters APTOSE BIOSCIENCES INC has filed alongside them.

FY2025 annual
Free Cash Flow -$22.0M
YoY +38.9%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

APTOF Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-K
Free Cash Flow-$22.0M+38.9%-$36.0M+19.4%-$44.6M-37.9%-$32.3M+25.7%-$43.5M-28.1%-$34.0M-56.8%-$21.7M+8.0%-$23.5M-129.9%-$10.2M

APTOF Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Free Cash FlowN/AN/AN/AN/AN/AN/AN/AN/AN/A-$9.3M-7.0%-$10.5M-51.0%-$13.5M-91.4%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More APTOSE BIOSCIENCES INC financials

Frequently Asked Questions

What was APTOSE BIOSCIENCES INC's free cash flow in fiscal year 2025?

APTOSE BIOSCIENCES INC recorded an outflow of $22.0M in free cash flow in fiscal year 2025.

How fast is APTOSE BIOSCIENCES INC's free cash flow growing?

APTOSE BIOSCIENCES INC (APTOF) free cash flow rose by 38.9% year over year, from -$36.0M to -$22.0M in fiscal year 2025.

How has APTOSE BIOSCIENCES INC's free cash flow changed over the years?

Across the 9 fiscal years this page covers, APTOSE BIOSCIENCES INC (APTOF) free cash flow went from -$10.2M in fiscal year 2017 to -$22.0M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what APTOSE BIOSCIENCES INC (APTOF) reported on that line in every period on record.